Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Divestments (2016 - 2020)

Nutex Health's Divestments history spans 3 years, with the latest figure at -$158744.0 for Q4 2020.

  • For Q4 2020, Divestments changed N/A year-over-year to -$158744.0; the TTM value through Dec 2021 reached -$158744.0, up 1.65%, while the annual FY2020 figure was -$161400.0, N/A changed from the prior year.
  • Divestments for Q4 2020 was -$158744.0 at Nutex Health, down from -$2656.0 in the prior quarter.
  • Across five years, Divestments topped out at $32848.0 in Q4 2017 and bottomed at -$158744.0 in Q4 2020.
  • The 3-year median for Divestments is -$2656.0 (2020), against an average of -$16763.0.
  • The largest YoY upside for Divestments was 401.58% in 2017 against a maximum downside of 401.58% in 2017.
  • A 3-year view of Divestments shows it stood at -$10892.0 in 2016, then soared by 401.58% to $32848.0 in 2017, then tumbled by 583.27% to -$158744.0 in 2020.
  • Per Business Quant, the three most recent readings for NUTX's Divestments are -$158744.0 (Q4 2020), -$2656.0 (Q1 2020), and $32848.0 (Q4 2017).